90012668 - Process For The Purification Of Duloxetine Hydrochloride
Details
Application Number: 90012668
Filing Date: 2012-09-15
Status: Decision - Certificate Issued
Last Updated: 2013-08-27
Examiner: Turner, Sharon L
Law Firm: Hunton Andrews Kurth LLP
Patent Owner: Teva Pharmaceuticals USA Inc
Requester: Grant E. Pollack PC
Timeline
Input Issue Number and Issue Date for Reexamination
Sep
Oct
Nov
Dec
2013
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2014
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2015
Feb
Transaction History
| 2013-08-27 | REEX | Input Issue Number and Issue Date for Reexamination |
| 2013-08-14 | RXPUBS | Reexam Forwarded to Office of Publications |
| 2013-08-09 | MRNRC | RX - Mail Notice of Intent to Issue a Reexam Certificate |
| 2013-08-05 | RXLITSR | Reexam Litigation Search Conducted |
| 2013-02-13 | RXFWDX | Date Forwarded to Examiner |
| 2013-02-12 | NRX. | Notice of Reexam Published in Official Gazette |
| 2012-12-06 | MR.NF | RX - Mail Reexam Non-Final Action |
| 2012-12-06 | MREXO | RX - Mail Ex Parte Request for Reexamination Granted |
| 2012-10-29 | MREXN | RX - Mail Examiner Interview Summary Record |
| 2012-10-26 | RXWVST | Waiver of owners statement in ex parte |
| 2012-10-24 | WROIPE | Application Return from OIPE |
| 2012-10-24 | MRXN | Reexamination Formalities Notice Mailed |
| 2012-10-24 | ROIPE | Application Return TO OIPE |
| 2012-10-23 | DOCK | Case Docketed to Examiner in GAU |
| 2012-10-22 | RXPCOM | Completion of Preprocessing - Released to Assigned GAU |
| 2012-10-22 | RXNREQFD | Notice of reexamination request filing date |
| 2012-10-22 | RXNREQAU | Notice of assignment of reexamination request |
| 2012-10-22 | RXTTLRPT | Title Report |
| 2012-09-15 | RXIDS. | Information Disclosure Statement Filed |
| 2012-09-15 | RXOSUB.R | Reexamination requested by third party requester |
| 2012-09-15 | RXOSUB | Receipt of Original Ex Parte Reexam Request |